Retrograde semaphorin signaling regulates synapse elimination in the developing mouse brain

Science

Volumn 344, Issue 6187, 2014, Pages 1020-1023

  Uesaka, Naofumi ^a   Uchigashima, Motokazu ^b   Mikuni, Takayasu ^a   Nakazawa, Takanobu ^a   Nakao, Harumi ^a   Hirai, Hirokazu ^c   Aiba, Atsu ^a   Watanabe, Masahiko ^b   Kano, Masanobu ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SEMAPHORIN; SEMAPHORIN 3A; SEMAPHORIN 7A; UNCLASSIFIED DRUG; LEUKOCYTE ANTIGEN; METABOTROPIC GLUTAMATE RECEPTOR TYPE 1; METABOTROPIC RECEPTOR; SEMA3A PROTEIN, MOUSE; SEMA7A PROTEIN, MOUSE;

BIOLOGICAL DEVELOPMENT; BRAIN; NEUROLOGY; PROTEIN; RODENT; SIGNALING;

ANIMAL CELL; ARTICLE; BRAIN DEVELOPMENT; CEREBELLUM; CONTROLLED STUDY; GENE SILENCING; MOUSE; NEWBORN; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN FUNCTION; PURKINJE CELL; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SYNAPSE ELIMINATION; SYNAPTIC TRANSMISSION; ANIMAL; BRAIN; C57BL MOUSE; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PHYSIOLOGY; RAT; RNA INTERFERENCE; SPRAGUE DAWLEY RAT; SYNAPSE;

ANIMALS; ANTIGENS, CD; BRAIN; GENE KNOCKDOWN TECHNIQUES; MICE; MICE, INBRED C57BL; PURKINJE CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, METABOTROPIC GLUTAMATE; RNA INTERFERENCE; SEMAPHORIN-3A; SEMAPHORINS; SIGNAL TRANSDUCTION; SYNAPSES;

EID: 84901654257     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1252514     Document Type: Article

References (19)

1. M. Kano, K. Hashimoto, Curr. Opin. Neurobiol. 19, 154-161 (2009).
2. M. Watanabe, M. Kano, Eur. J. Neurosci. 34, 1697-1710 (2011).
3. J. W. Lichtman, H. Colman, Neuron 25, 269-278 (2000).
4. M. Kano et al., Cell 83, 1223-1231 (1995).
5. M. Kano et al., Neuron 18, 71-79 (1997).
6. F. Crepel, Trends Neurosci. 5, 266-269 (1982).
7. N. Uesaka et al., J. Neurosci. 32, 11657-11670 (2012).
8. T. Mikuni et al., Neuron 78, 1024-1035 (2013).
9. K. Hashimoto et al., Proc. Natl. Acad. Sci. U.S.A. 108, 9987-9992 (2011).
10. K. Hashimoto, R. Ichikawa, K. Kitamura, M. Watanabe, M. Kano, Neuron 63, 106-118 (2009).
11. F. Crepel, N. Delhaye-Bouchaud, J. L. Dupont, Brain Res. Dev. Brain Res. 1, 59-71 (1981).
12. K. Hashimoto, M. Kano, Neuron 38, 785-796 (2003).
13. S. Kakizawa, M. Yamasaki, M. Watanabe, M. Kano, J. Neurosci. 20, 4954-4961 (2000).
14. K. Hashimoto et al., J. Neurosci. 21, 9701-9712 (2001).
15. T. Miyazaki, K. Hashimoto, H. S. Shin, M. Kano, M. Watanabe, J. Neurosci. 24, 1734-1743 (2004).
16. R. J. Pasterkamp, Nat. Rev. Neurosci. 13, 605-618 (2012).
17. R. J. Pasterkamp, J. J. Peschon, M. K. Spriggs, A. L. Kolodkin, Nature 424, 398-405 (2003).
18. G. A. Scott, L. A. McClelland, A. F. Fricke, A. Fender, J. Invest. Dermatol. 129, 954-963 (2009).
19. H. Hirai, T. Torashima, Japanese Patent 4975733 (2012).